DNA-linked enzyme-coupled assay for high-throughput monitoring
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current enzyme characterization methods are low-throughput, limiting the scalability of enzyme activity monitoring and engineering efforts in synthetic biology and biotechnology, particularly in the context of glycosyltransferases where stringent specificity hampers natural product diversification and drug development.
Innovation Solution
The DNA-linked enzyme-coupled assay (DLEnCA) method, which combines PCR and cell-free transcription/translation systems to monitor enzyme reactions by linking enzymatic output to DNA modifications, eliminating the need for protein purification and liquid chromatography mass spectrometry, and enabling high-throughput analysis using agarose gels, quantitative PCR, or next-generation sequencing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional enzyme characterization methods (LCMS, GCMS) are used, then measurement precision is maintained, but productivity is severely limited due to laborious procedures and low throughput
Solution Approach 1:
The patent introduces a DNA-linked enzyme-coupled assay where a DNA intermediate serves as a mediator between the enzyme reaction and detection. The enzyme of interest modifies a substrate, which then modifies a DNA probe, creating a detectable signal. This intermediary system enables high-throughput monitoring without requiring complex LCMS or GCMS equipment, thus improving productivity while maintaining measurement capability.
Solution Approach 2:
The patent replaces complex mechanical/chemical analysis systems (LCMS, GCMS) with a simpler biochemical assay system based on DNA modification and detection. By substituting the detection mechanism from mass spectrometry to DNA-based readout, the system achieves high throughput with reduced procedural complexity and equipment requirements.
2Measurement precision
If protein purification and LCMS are used for enzyme analysis, then measurement precision is ensured, but loss of time is excessive due to laborious procedures
Solution Approach 1:
The patent employs preliminary action by pre-designing DNA probes with specific modification sites that are ready to detect enzyme activity directly. The DNA probes are prepared in advance with known sequences and modification positions, allowing immediate detection when the enzyme acts on the substrate. This eliminates the need for time-consuming protein purification and LCMS analysis, significantly reducing the time required for enzyme characterization while maintaining detection accuracy.
3Manufacturing precision
If stringent specificity is applied in glycosyltransferases, then manufacturing precision of natural products is improved, but adaptability for natural product diversification is reduced
Solution Approach 1:
The patent implements feedback by using the DNA-linked assay to monitor and measure the activity and specificity of glycosyltransferases in real-time. The detection system provides quantitative information about enzyme performance, allowing researchers to identify and select enzymes with optimal specificity for desired natural product modifications. This feedback mechanism enables systematic exploration of enzyme variants and their impact on product diversity, balancing manufacturing precision with adaptability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
DLEnCA facilitates high-throughput and cost-effective enzyme characterization, allowing for the monitoring of enzyme activity and specificity, thereby overcoming the limitations of traditional low-throughput methods and enhancing the scalability of enzyme engineering efforts.
Implementation Method 1
combines PCR and cell-free transcription/translation systems to generate protein
Implementation Method 2
combines PCR and cell-free transcription/translation systems to generate protein
Implementation Method 3
the enzyme of interest to modify the at least one substrate with a moiety derived from the at least one cofactor
Implementation Method 4
a second enzyme capable of using the at least one cofactor to modify a nucleic acid of the polynucleotide
Data Source
AI summary
Traditional enzyme characterization methods are low-throughput, and therefore limit engineering efforts in synthetic biology and biotechnology. Here we propose a DNA-linked enzyme-coupled assay (DLEnCA) to monitor enzyme reactions in a high-throughput manner. Throughput is improved by removing the need for protein purification and by limiting the need for liquid chromatography mass spectrometry (LCMS) product detection by linking enzymatic function to DNA modification. DLEnCA is generalizable for many enzymatic reactions, and here we adapt it for glucosyltransferases, methyltransferases, and oxidoreductases. The assay utilizes cell free transcription/translation systems to produce enzymes of interest, while UDP-Glucose and T4-β-glucosyltransferase are used to modify DNA, which is detected post-reaction using qPCR or similar means of DNA analysis. For monitoring methyltransferases, consumption of SAM is observed by coupling to EcoRI methyltransferase. For monitoring oxidoreductases, consumption of NADH is observed by coupling to Taq or E. coli DNA ligase. OleD and two glucosyltransferases from Arabidopsis were used to verify the assay's generality toward glucosyltransferases. Two methyltransferases from human and Arabidopsis were used to verify the assay's generality towards methyltransferases. We show DLEnCA's utility by mapping out the substrate specificity for these enzymes and observing the multiple steps of a biosynthetic pathway.